ArticleOncotarget2016

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

Srikanth R Ambati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.